Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review

Clinical Lymphoma, Myeloma & Leukemia
Chelsea C PinnixBouthaina Shbib Dabaja

Abstract

Plasmablastic lymphoma (PBL) is an aggressive variant of diffuse large B-cell lymphoma. We sought to assess the treatment outcomes after combined-modality therapy for early-stage PBL. We retrospectively reviewed the outcomes of 10 consecutive patients diagnosed with stage I-II PBL from February 2001 to December 2013 at a single institution. The baseline clinical characteristics, treatment modalities, overall outcomes, and treatment-related toxicity were assessed. The median age at diagnosis was 50.5 years. All patients had extranodal disease; 2 were positive for human immunodeficiency virus. Seven patients received hyper-CVAD (cyclophosphamide, vincristine, doxorubicin, dexamethasone)-based chemotherapy, 2 received CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone), and 1 received dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin). Radiotherapy (RT) was administered after a complete response to chemotherapy in 7 patients and a partial response in 1 patient. At a median follow-up period of 42 months, the estimated 2-year progression-free and overall survival rates were 90% and 100%, respectively. PBL can be successfully treated with aggressive chemotherapy followed by RT. The treat...Continue Reading

References

Mar 30, 1995·International Journal of Radiation Oncology, Biology, Physics·J D CoxT F Pajak
Mar 18, 2008·Journal of the American Academy of Dermatology·Anokhi JambusariaClifford Perlis
Apr 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wyndham H WilsonJohn E Janik
Aug 30, 2008·American Journal of Hematology·Jorge CastilloBruce J Dezube
Oct 23, 2008·Oral Diseases·P Rafaniello RavieleE Maiorano
Sep 19, 2009·American Journal of Clinical Pathology·Agata M BoguszWeina Chen
Aug 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jack PhanBouthaina Shbib Dabaja
Oct 22, 2010·The American Journal of Surgical Pathology·Alexandra ValeraElías Campo
May 18, 2011·Clinical Lymphoma, Myeloma & Leukemia·Jorge J CastilloJames N Butera
Aug 1, 2013·Current Hematologic Malignancy Reports·Belinda A Campbell
Sep 26, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerhard HeldMichael Pfreundschuh
Dec 18, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Alexandar TzankovKen H Young
Apr 15, 2014·International Journal of Radiation Oncology, Biology, Physics·Tim IllidgeUNKNOWN International Lymphoma Radiation Oncology Group
Jun 21, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Monzr M Al-MalkiAlessandro Re
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonT Andrew Lister

❮ Previous
Next ❯

Citations

Mar 2, 2016·Annals of Hematology·Keichiro MiharaShinichi Suehiro
Sep 12, 2016·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·C Demoor-GoldschmidtM A Mahé
Feb 9, 2019·American Journal of Hematology·Nivedita AroraNavid Sadeghi
Jan 10, 2021·Clinical Lymphoma, Myeloma & Leukemia·Nafie F MakadyKyrillus S Shohdy
Jun 7, 2021·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Felipe Paiva FonsecaWillie F P van Heerden

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.